BAY 1143269

BAY 1143269 · Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAY 1143269, covering 2018-03-07 to 2018-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel [Phase 1]